75 related articles for article (PubMed ID: 7551239)
21. Development of synthetic immunoadjuvants as cytokine inducers for cancer therapy.
Mihich E
Jpn J Cancer Res; 1996 Jul; 87(7):inside front cover. PubMed ID: 8698612
[No Abstract] [Full Text] [Related]
22. Nano- and microparticles as adjuvants in vaccine design: success and failure is related to host natural antibodies.
Sinyakov MS; Dror M; Lublin-Tennenbaum T; Salzberg S; Margel S; Avtalion RR
Vaccine; 2006 Oct; 24(42-43):6534-41. PubMed ID: 16842893
[TBL] [Abstract][Full Text] [Related]
23. Aluminium phosphate potentiates the efficacy of DNA vaccines against Leishmania mexicana.
Rosado-Vallado M; Mut-Martin M; García-Miss Mdel R; Dumonteil E
Vaccine; 2005 Nov; 23(46-47):5372-9. PubMed ID: 16054271
[TBL] [Abstract][Full Text] [Related]
24. Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey.
Verdier F; Burnett R; Michelet-Habchi C; Moretto P; Fievet-Groyne F; Sauzeat E
Vaccine; 2005 Feb; 23(11):1359-67. PubMed ID: 15661384
[TBL] [Abstract][Full Text] [Related]
25. A need for effective adjuvants.
Bunce CJ; Morse MA
Curr Opin Mol Ther; 2003 Feb; 5(1):8-9. PubMed ID: 12669464
[No Abstract] [Full Text] [Related]
26. Aluminium-based adjuvants should not be used as placebos in clinical trials.
Exley C
Vaccine; 2011 Nov; 29(50):9289. PubMed ID: 21871940
[No Abstract] [Full Text] [Related]
27. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
[TBL] [Abstract][Full Text] [Related]
28. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
Gupta RK; Griffin P; Rivera R; Siber GR
Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
[TBL] [Abstract][Full Text] [Related]
29. Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine.
Nøkleby H
Expert Rev Vaccines; 2007 Oct; 6(5):863-9. PubMed ID: 17931164
[TBL] [Abstract][Full Text] [Related]
30. In vitro interactions between macrophages and aluminum-containing adjuvants.
Rimaniol AC; Gras G; Clayette P
Vaccine; 2007 Sep; 25(37-38):6784-92. PubMed ID: 17689842
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of aluminum and ouabain on synaptosomal choline uptake, acetylcholine release and (Na+/K+)ATPase.
Silva VS; Nunes MA; Cordeiro JM; Calejo AI; Santos S; Neves P; Sykes A; Morgado F; Dunant Y; Gonçalves PP
Toxicology; 2007 Jul; 236(3):158-77. PubMed ID: 17560001
[TBL] [Abstract][Full Text] [Related]
32. Bioneedles as vaccine carriers.
Hirschberg HJ; van de Wijdeven GG; Kelder AB; van den Dobbelsteen GP; Kersten GF
Vaccine; 2008 May; 26(19):2389-97. PubMed ID: 18406021
[TBL] [Abstract][Full Text] [Related]
33. In vitro aluminum inhibition of brain phosphoinositide metabolism: comparison of neonatal and adult rats.
Mundy WR; Freudenrich T; Shafer TJ; Nostrandt AC
Neurotoxicology; 1995; 16(1):35-44. PubMed ID: 7603643
[TBL] [Abstract][Full Text] [Related]
34. A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.
Langley JM; Sales V; McGeer A; Guasparini R; Predy G; Meekison W; Li M; Capellan J; Wang E
Vaccine; 2009 Sep; 27(42):5913-9. PubMed ID: 19651171
[TBL] [Abstract][Full Text] [Related]
35. Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model.
Mawas F; Dickinson R; Douglas-Bardsley A; Xing DK; Sesardic D; Corbel MJ
Vaccine; 2006 Apr; 24(17):3505-12. PubMed ID: 16524648
[TBL] [Abstract][Full Text] [Related]
36. Effects of low-molecular-weight aluminum complexes on brain tissue calcium homeostasis.
Anghileri LJ; Thouvenot P; Bertrand A
Biol Trace Elem Res; 1998 Sep; 63(3):205-12. PubMed ID: 9840816
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the adjuvanticity of aluminum salts and their combination in hepatitis B recombinant protein vaccine in assessed mice.
Mahboubi A; Fazeli MR; Dinarvand R; Samadi N; Sharifzadeh M; Ilka H; Azadi S; Soleimanian R; Kalkouei H; Hajikhanmirzaei R; Valadkhani M
Iran J Immunol; 2008 Sep; 5(3):163-70. PubMed ID: 18791283
[TBL] [Abstract][Full Text] [Related]
38. [Effect of aluminum and iron on lipid metabolism in aquatic invertebrates].
Regerand TI; Nefedova ZA; nemova NN; Ruokalaĭnen TR; Toĭvonen LV; Dubrovina LV; Vuori KM; Markova LV
Prikl Biokhim Mikrobiol; 2005; 41(2):220-7. PubMed ID: 15859468
[TBL] [Abstract][Full Text] [Related]
39. Summaries of round-table discussions.
Hum Exp Toxicol; 2000 Apr; 19(4):213-8. PubMed ID: 10918510
[No Abstract] [Full Text] [Related]
40. [Influence of oral administration of aluminum chloride on intestinal transport of leucine and methionine].
Sedrowicz LW; Oledzka R; van der Voet GB; de Wolff FA
Rocz Panstw Zakl Hig; 1993; 44(1):103. PubMed ID: 8235335
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
